Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]The Netherlands Cancer Institute"
Count: 220
Selected: 0
| NCT ID | Title |
|---|
| NCT04699292 | International Prospective Registry on Local Treatment Approaches in MLS | ||
| NCT04231175 | Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer | ||
| NCT01780675 | Hippocampus Avoidance PCI vs PCI | ||
| NCT03223727 | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 | ||
| NCT03984019 | Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis | ||
| NCT03772028 | Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | ||
| NCT04871594 | Checkpoint Inhibition With or Without Domatinostat in Urothelial Cancer | ||
| NCT04949113 | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma | ||
| NCT03367780 | Dose-Effect Relation of Salivary Gland Irradiation | ||
| NCT01504815 | Adaptive Radiation Treatment for Head and Neck Cancer | ||
| NCT04425967 | Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas | ||
| NCT04351204 | The MR-Linac Technical Feasibility Protocol | ||
| NCT03540563 | ctDNA as a Biomarker for Treatment Response in HNSCC | ||
| NCT02910895 | Sarcoma Patient Derived Xenografts | ||
| NCT02229656 | Olaparib and Radiotherapy in Head and Neck Cancer | ||
| NCT02227082 | Olaparib and Radiotherapy in Inoperable Breast Cancer | ||
| NCT02106312 | Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas | ||
| NCT04971421 | Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer | ||
| NCT04161664 | Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy | ||
| NCT04648189 | Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC | ||
| NCT02810743 | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer | ||
| NCT01898117 | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer | ||
| NCT02913729 | Pre- Versus Postoperative Accelerated Partial Breast Irradiation | ||
| NCT04916236 | Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | ||
| NCT03348150 | Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. | ||
| NCT03295565 | Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel | ||
| NCT04307329 | Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial | ||
| NCT04017455 | Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) | ||
| NCT03448835 | Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) | ||
| NCT03026140 | Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity | ||
| NCT02695459 | Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin | ||
| NCT03394716 | Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors | ||
| NCT03387761 | Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy | ||
| NCT03686332 | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study | ||
| NCT02492607 | Management of Low-risk (Grade I and II) DCIS | ||
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | ||
| NCT03871036 | Improve Checkpoint-blockade Response in Advanced Urothelial Cancer | ||
| NCT04287829 | Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients | ||
| NCT03003637 | ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma | ||
| NCT04737382 | Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. | ||
| NCT02826512 | A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients | ||
| NCT04148066 | ctDNA Guided Treatment of Early Resistance to Targeted Treatment | ||
| NCT01359397 | Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer | ||
| NCT04082988 | Early Response Evaluation in NSCLC Patients Treated With Immunotherapy | ||
| NCT04159818 | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients | ||
| NCT03819829 | Blood Sampling of Healthy Volunteers for Immunological Research | ||
| NCT03815890 | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | ||
| NCT03147040 | AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer | ||
| NCT03126812 | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer | ||
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab |
